Search research articles
Contact Us
Filters
Showing results (1011-1020 of 1,095) with videos related to
Page
of 110
Sort By:
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
October 6, 2023
Mechanisms by which the cystic fibrosis transmembrane conductance regulator may influence SARS-CoV-2 infection and COVID-19 disease severity
Philip R Tedbury, Candela Manfredi, Frauke Degenhardt, et al.
Cancer Immunology, Immunotherapy : CII
|
May 29, 2023
Real-world effectiveness of pembrolizumab as first-line therapy for cisplatin-ineligible patients with advanced urothelial carcinoma: the ARON-2 study
Matteo Santoni, Zin W Myint, Thomas Büttner, et al.
European Urology Focus
|
July 30, 2025
Immune-based Combinations in Intermediate-/Poor-risk Patients with Non-clear Cell Renal Cell Carcinoma: Results from the ARON-1 Study
Francesco Massari, Veronica Mollica, Ray Manneh Kopp, et al.
Veterinary Parasitology, Regional Studies and Reports
|
April 25, 2025
A tale of a snail: Fatal meningoencephalitis caused by Angiostrongylus cantonensis in a spider monkey (Ateles chamek) and detection among snails, São Paulo, Brazil
Natália C C de A Fernandes, Eduardo Ferreira-Machado, Jamile Macedo Garcia, et al.
Journal of Hepatology
|
July 25, 2020
aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis
Rong Fan, George Papatheodoridis, Jian Sun, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
October 5, 2022
Securing wider EU commitment to the elimination of hepatitis C virus
Heiner Wedemeyer, Tammo L Tergast, Jeffrey V Lazarus, et al.
Cancer Immunology, Immunotherapy : CII
|
February 3, 2026
Effectiveness of ICI-ICI versus ICI-TKI combinations in patients with IMDC intermediate- and poor-risk metastatic renal cell carcinoma: a sub-analysis of the MEET-URO 33 study
Michele Maffezzoli, Alessio Signori, Alessandro Acunzo, et al.
Journal for Immunotherapy of Cancer
|
May 21, 2021
INfluenza Vaccine Indication During therapy with Immune checkpoint inhibitors: a multicenter prospective observational study (INVIDIa-2)
Melissa Bersanelli, Diana Giannarelli, Ugo De Giorgi, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
July 3, 2025
Risk Factors of Metabolic Dysfunction-associated Steatotic Liver Disease in a Cohort of Patients With Chronic Hepatitis B
Maria Kalafateli, Roberta Forlano, Eleanor Barnes, et al.
The Oncologist
|
February 24, 2019
Clinical Outcomes of Patients with Advanced Cancer and Pre-Existing Autoimmune Diseases Treated with Anti-Programmed Death-1 Immunotherapy: A Real-World Transverse Study
Alessio Cortellini, Sebastiano Buti, Daniele Santini, et al.
Page
of 110
Search research articles
Search
Showing results (1011-1020 of 1,095) with videos related to
Sort By:
Page
of 110
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
October 6, 2023
Mechanisms by which the cystic fibrosis transmembrane conductance regulator may influence SARS-CoV-2 infection and COVID-19 disease severity
Philip R Tedbury, Candela Manfredi, Frauke Degenhardt, et al.
Cancer Immunology, Immunotherapy : CII
|
May 29, 2023
Real-world effectiveness of pembrolizumab as first-line therapy for cisplatin-ineligible patients with advanced urothelial carcinoma: the ARON-2 study
Matteo Santoni, Zin W Myint, Thomas Büttner, et al.
European Urology Focus
|
July 30, 2025
Immune-based Combinations in Intermediate-/Poor-risk Patients with Non-clear Cell Renal Cell Carcinoma: Results from the ARON-1 Study
Francesco Massari, Veronica Mollica, Ray Manneh Kopp, et al.
Veterinary Parasitology, Regional Studies and Reports
|
April 25, 2025
A tale of a snail: Fatal meningoencephalitis caused by Angiostrongylus cantonensis in a spider monkey (Ateles chamek) and detection among snails, São Paulo, Brazil
Natália C C de A Fernandes, Eduardo Ferreira-Machado, Jamile Macedo Garcia, et al.
Journal of Hepatology
|
July 25, 2020
aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis
Rong Fan, George Papatheodoridis, Jian Sun, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
October 5, 2022
Securing wider EU commitment to the elimination of hepatitis C virus
Heiner Wedemeyer, Tammo L Tergast, Jeffrey V Lazarus, et al.
Cancer Immunology, Immunotherapy : CII
|
February 3, 2026
Effectiveness of ICI-ICI versus ICI-TKI combinations in patients with IMDC intermediate- and poor-risk metastatic renal cell carcinoma: a sub-analysis of the MEET-URO 33 study
Michele Maffezzoli, Alessio Signori, Alessandro Acunzo, et al.
Journal for Immunotherapy of Cancer
|
May 21, 2021
INfluenza Vaccine Indication During therapy with Immune checkpoint inhibitors: a multicenter prospective observational study (INVIDIa-2)
Melissa Bersanelli, Diana Giannarelli, Ugo De Giorgi, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
July 3, 2025
Risk Factors of Metabolic Dysfunction-associated Steatotic Liver Disease in a Cohort of Patients With Chronic Hepatitis B
Maria Kalafateli, Roberta Forlano, Eleanor Barnes, et al.
The Oncologist
|
February 24, 2019
Clinical Outcomes of Patients with Advanced Cancer and Pre-Existing Autoimmune Diseases Treated with Anti-Programmed Death-1 Immunotherapy: A Real-World Transverse Study
Alessio Cortellini, Sebastiano Buti, Daniele Santini, et al.
Page
of 110